Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Crohn’s Disease: 2025 AGA Evidence Synthesis

By afschroeder • October 21, 2025

Singh S, Murad MH, Yuan Y, Ananthakrishnan AN, Click B, Syal G, Haydek JP, Agrawal M, Kappelman MD, Lewis JD, Scott FI. Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Crohn's Disease: 2025 AGA Evidence Synthesis. Gastroenterology. 2025 Oct 20:S0016-5085(25)05964-5. doi: 10.1053/j.gastro.2025.08.032. Epub ahead of print. PMID: 41114682.

Tags: Biologics, Comparative Effectiveness, Digestive Diseases, guidelines, Inflammatory Bowel Diseases, Positioning, Publications

Liver Metabolomic Profiling Reveals Distinct Signatures Between Steatosis and Metabolic Dysfunction-Associated Steatohepatitis

Palomurto S, Flam E, Kaminska D, Virtanen KA, Kärjä V, Käkelä P, Pajukanta P, Eberlé D, Haas JT, Raverdy V, Caiazzo R, Pattou F, Staels[...]

Medications for Alcohol Use Disorder Among Patients With Severe Alcohol-Related Liver Disease

Sundaresh R, Singh J, Meza J, Saab S, Shetty A. Medications for Alcohol Use Disorder Among Patients With Severe Alcohol-Related Liver Disease. JAMA Netw Open.[...]

Quality of Gadoxetate-enhanced MRI versus US during Hepatocellular Carcinoma Screening in Participants with Cirrhosis

Lewis S, Wildman-Tobriner B, Cuevas J, Calle S, Bolger I, Wang K, Joshi H, Mankowski Gettle L, Yang JD, Min JH, Sirlin CB, Reeder SB,[...]